Designing Clinical Trials for Focal Salvage Ablation
Most men with radiation-recurrent prostate cancer once had few good options — hormone therapy delayed the disease but offered no hope of cure. Today, focal salvage ablation is changing that picture. Now, a global expert panel has outlined the clinical trial standards needed to put this promising treatment on solid scientific footing. keep reading
